Correction to: BMC Urology (2023) 23:1
10.1186/s12894-022-01172-8
Following publication of the original article [1], In table 1, First line, second column, “Received chemotherapy” were supposed to be “Unreceived chemotherapy”. First line, third column, “Unreceived chemotherapy” were supposed to be “Received chemotherapy”.
The original article has been corrected.
Table 1.
Demographics, clinicopathologic characteristics, and therapeutic information of the enrolled UTUC patients.
| Characteristics | Unreceived chemotherapy | Received chemotherapy | Total | P value |
|---|---|---|---|---|
|
Number of patients (%) Age (years) |
4441 (77.9%) | 1257 (22.1%) | 5698 (100%) | < 0.001* |
| Mean (SD) | 72.1 (11.0) | 67.2 (10.4) | 71.1 (11.1) | |
| Sex | 0.076 | |||
| Female | 1943 (43.8%) | 514 (40.9%) | 2457 (43.1%) | |
| Male | 2498 (56.2%) | 743 (59.1%) | 3241 (56.9%) | |
| Race | < 0.001* | |||
| White | 3887 (87.5%) | 1051 (83.6%) | 4938 (86.7%) | |
| Black | 185 (4.2%) | 53 (4.2%) | 238 (4.2%) | |
| Other | 369 (8.3%) | 153 (12.2%) | 522 (9.2%) | |
| Marital status | < 0.001* | |||
| Married | 2658 (59.9%) | 890 (70.8%) | 3548 (62.3%) | |
| Divorced/widowed/Separated | 1363 (30.7%) | 248 (19.7%) | 1611 (28.3%) | |
| Unmarried/Single | 420 (9.5%) | 119 (9.5%) | 539 (9.5%) | |
| Primary Site | 0.358 | |||
| Renal Pelvis | 2933 (66.0%) | 812 (64.6%) | 3745 (65.7%) | |
| Ureter | 1508 (34.0%) | 445 (35.4%) | 1953 (34.3%) | |
| Grade | < 0.001* | |||
| Grade I | 246 (5.5%) | 21 (1.7%) | 267 (4.7%) | |
| Grade II | 801 (18.0%) | 77 (6.1%) | 878 (15.4%) | |
| Grade III | 1253 (28.2%) | 404 (32.1%) | 1657 (29.1%) | |
| Grade IV | 2141 (48.2%) | 755 (60.1%) | 2896 (50.8%) | |
| T Stage | < 0.001* | |||
| T1 | 1642 (37.0%) | 177 (14.1%) | 1819 (31.9%) | |
| T2 | 881 (19.8%) | 132 (10.5%) | 1013 (17.8%) | |
| T3 | 1598 (36.0%) | 694 (55.2%) | 2292 (40.2%) | |
| T4 | 320 (7.2%) | 254 (20.2%) | 574 (10.1%) | |
| N Stage | < 0.001* | |||
| N0 | 4123 (92.8%) | 779 (62.0%) | 4902 (86.0%) | |
| N1 | 186 (4.2%) | 262 (20.8%) | 448 (7.9%) | |
| N2 | 132 (3.0%) | 216 (17.2%) | 348 (6.1%) | |
| M Stage | < 0.001* | |||
| M0 | 4286 (96.5%) | 1024 (81.5%) | 5310 (93.2%) | |
| M1 | 155 (3.5%) | 233 (18.5%) | 388 (6.8%) | |
| Radiation | 1.000 | |||
| No/Unknown | 19 (0.4%) | 6 (0.5%) | 25 (0.4%) | |
| Yes | 4422 (99.6%) | 1251 (99.5%) | 5673 (99.6%) | |
| Surgical methods of the primary site | < 0.001* | |||
| No | 26 (0.6%) | 124 (9.9%) | 150 (2.6%) | |
| Local Mass resection/destruction | 163 (3.7%) | 49 (3.9%) | 212 (3.7%) | |
| Partial nephrectomy/ureterectomy | 472 (10.6%) | 114 (9.1%) | 586 (10.3%) | |
| Radical nephroureterectomy | 2600 (58.5%) | 586 (46.6%) | 3186 (55.9%) | |
| Radical nephrectomy | 1014 (22.8%) | 324 (25.8%) | 1338 (23.5%) | |
| Multivisceral resection | 166 (3.7%) | 60 (4.8%) | 226 (4.0%) | |
| Surgery of Lymph nodes (LNs) | < 0.001* | |||
| No | 3413 (76.9%) | 716 (57.0%) | 4129 (72.5%) | |
| 1 to 3 regional LNs removed | 610 (13.7%) | 268 (21.3%) | 878 (15.4%) | |
| 4 or more regional LNs removed | 418 (9.4%) | 273 (21.7%) | 691 (12.1%) |
*P < 0.05 indicating statistical significance.
Footnotes
The online version of the original article can be found at 10.1186/s12894-022-01172-8.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Tian C, Liu J, An L, Hong Y, Xu Q. Prognostic nomogram for overall survival in upper urinary tract urothelial carcinoma (UTUC) patients treated with chemotherapy: a SEER-based retrospective cohort study. BMC urology. 2023 Dec;23(1):1–2. [DOI] [PMC free article] [PubMed]